the dct effect on talent management.
While many of the workflows and regulatory pathways for decentralized or hybrid trials resemble traditional protocols, the people piece of it is markedly different. Consider this the “DCT effect” of talent management. It’s a phenomenon impacting not just who drug developers hire but also where and how.
For one thing, decentralized trials require specialized skill sets — people familiar with certain platforms who can manage the nuanced needs of remote research. But in this war for talent, that’s becoming harder to find and keep, suggests John Ebeid, Senior Vice President of Randstad Life Sciences.
